CoChat

An open label trial of C-1073 (mifepristone) for psychotic major depression*

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.

Abstract

Background The rationale for treating patients with psychotic major depression (PMD) with glucocorticosteroid receptor (GR) antagonists is explained.Methods Thirty patients with PMD, with Hamilton Rating Scale for Depression (HAMD-21) scores of 18 or greater, were assigned in an open label trial to receive 50 mg, 600 mg, or 1200 mg of mifepristone for 7 days.Results All the subjects completed the protocol; there were no dropouts. Side effects were mild and sporadic. Of 19 subjects in the combined 600- and 1200-mg group, 13 had a 30% or greater decline in their Brief Psychiatric Rating Scale (BPRS) scores, compared with 4 of 11 in the 50-mg group. In the 600- and 1200-mg group, 12 of 19 subjects showed a 50% decline in the BPRS positive symptom subscale, a more sensitive index for the symptoms seen in PMD, compared with 3 of 11 in the 50-mg group; 8 of 19 subjects in the 600- and 1200-mg group had a 50% decline in the HAMD-21, compared with 2 of 11 in the 50-mg group.Conclusions These results suggest that short term use of GR antagonists may be effective in the treatment of psychotic major depression and that further blinded studies are warranted.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-3223(02)01432-4

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Research works printed but not linked: 9

  1. Ammar, 1986, Letter, Am J Psychiatry, 143, 129
  2. Bertagna, 1994, Administration of RU486 for 8 Days in normal volunteers, J Clin Endocrinol Metab, 78, 375
  3. Chrousos GP, Laue L, Nieman LK, Udelsman R, Kawai S, Loriaux DL (1989): Clinical applications of RU 486, a prototype glucocorticoid and progestin antagonist. In: The Adrenal and Hypertension: From Cloning to Clinic 57 of Serono Symposia. New York: Raven Press, pp 273–284
  4. Gaillard, 1984, RU 486, Med Sci, 81, 3879
  5. Herrmann, 1982, Effet d’un steroide anti-progesterone chez la femme, Comtes Rendus, 294, 922
  6. Murphy, 1993, Possible use of glucocorticoid receptor antagonists in the treatment of major depression, J Psychiatr Neurosci, 18, 209
  7. Nobler, 1997, Quantifying the speed of symptomatic improvement with electroconvulsive therapy, Convuls Ther, 13, 208
  8. Rothschild, 1985, Delusional depression, McLean Hosp J, 10, 68
  9. Swartz, 1985, Electroconvulsive therapy-induced cortisol release, Convul Ther, 1, 15

Cited by

See all 345

Metadata

Authors
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F.
Affiliations
  • Corcept Therapeutics (United States) (US)
  • University of Massachusetts Chan Medical School (US)
  • Duke University (US)
  • Stanford University (US)
  • Duke Clinical Research Institute (US)
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2002-09
Volume
52
Issue
5
Pages
386-392
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2005817345
Cited by
320
References
71
Citations by year
2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 1 · 2016: 10 · 2015: 5 · 2014: 13 · 2013: 10 · 2012: 14
FWCI
18.76
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
National Institute of Mental Health (T32-MH19983, R01MH050604, MH50604)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
mifepristone, psychotic depression, glucocorticoid receptor antagonist, antidepressant efficacy, dose comparison, positive psychotic symptoms, Brief Psychiatric Rating Scale, Hamilton Depression Rating Scale
MeSH terms
Adult, Aged, Major Depressive Disorder, Dose-Response Relationship, Drug, Female, Hormone Antagonists, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Mifepristone, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An open label trial of C-1073 (mifepristone) for psychotic major depression*. https://app.cochat.ai/papers/10.1016/s0006-3223(02)01432-4
The paper
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression*. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(02)01432-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.